Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 3/2011

01.03.2011 | Article

Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults

verfasst von: N. Miyashita, Y. Kawai, T. Yamaguchi, K. Ouchi, M. Oka, Atypical Pathogen Study Group

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The purpose of the present study was to evaluate the accuracy and usefulness of three rapid diagnostic methods, ImmunoCard Mycoplasma kit, chest high-resolution computed tomography (HRCT) findings, and the Japanese Respiratory Society (JRS) scoring system (including six parameters), for the early presumptive diagnosis of Mycoplasma pneumoniae pneumonia in adults. We performed three rapid diagnostic methods at the same time in four pneumonia groups: 68 cases with M. pneumoniae pneumonia, 133 cases with Streptococcus pneumoniae pneumonia, 30 cases with Haemophilus influenzae pneumonia, and 20 cases with Legionella pneumonia. The sensitivity and specificity were 35% and 68% for ImmunoCard, 73% and 85% with HRCT, and 83% and 90% with the JRS scoring system, respectively. Among the three rapid diagnostic methods, the JRS scoring system was the most useful tool for initiating the administration of adequate antibiotic therapy for probable M. pneumoniae pneumonia. We suggest that M. pneumoniae pneumonia should be suspected when there is a correlation of more than five parameters in the JRS scoring system (99% specificity). If there is a correlation of three or four parameters in the JRS scoring system, chest computed tomography (CT) findings are helpful for the presumptive diagnosis of M. pneumoniae pneumonia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Atkinson TP, Balish MF, Waites KB (2008) Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 32:956–973CrossRefPubMed Atkinson TP, Balish MF, Waites KB (2008) Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 32:956–973CrossRefPubMed
2.
Zurück zum Zitat Miyashita N, Fukano H, Mouri K, Fukuda M, Yoshida K, Kobashi Y, Niki Y, Oka M (2005) Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol 54:395–400CrossRefPubMed Miyashita N, Fukano H, Mouri K, Fukuda M, Yoshida K, Kobashi Y, Niki Y, Oka M (2005) Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol 54:395–400CrossRefPubMed
3.
Zurück zum Zitat Matsushima T, Kohno S, Saito A et al (eds) (2005) The JRS guidelines for the management of community-acquired pneumonia in adults (in Japanese). The committee for the JRS guidelines in management of respiratory infections, the Japanese Respiratory Society, Tokyo, Japan Matsushima T, Kohno S, Saito A et al (eds) (2005) The JRS guidelines for the management of community-acquired pneumonia in adults (in Japanese). The committee for the JRS guidelines in management of respiratory infections, the Japanese Respiratory Society, Tokyo, Japan
4.
Zurück zum Zitat Miyashita N, Ouchi K, Kawasaki K, Oda K, Kawai Y, Shimizu H, Kobashi Y, Oka M (2008) Mycoplasma pneumoniae pneumonia in the elderly. Med Sci Monit 14:CR387–CR391PubMed Miyashita N, Ouchi K, Kawasaki K, Oda K, Kawai Y, Shimizu H, Kobashi Y, Oka M (2008) Mycoplasma pneumoniae pneumonia in the elderly. Med Sci Monit 14:CR387–CR391PubMed
5.
Zurück zum Zitat Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom S-J, Lipman HB, Kolczak MS, Breiman RF; The Community-Based Pneumonia Incidence Study Group (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch Intern Med 157:1709–1718CrossRefPubMed Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom S-J, Lipman HB, Kolczak MS, Breiman RF; The Community-Based Pneumonia Incidence Study Group (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch Intern Med 157:1709–1718CrossRefPubMed
6.
Zurück zum Zitat Miyashita N, Fukano H, Okimoto N, Hara H, Yoshida K, Niki Y, Matsushima T (2002) Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 121:1776–1781CrossRefPubMed Miyashita N, Fukano H, Okimoto N, Hara H, Yoshida K, Niki Y, Matsushima T (2002) Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 121:1776–1781CrossRefPubMed
7.
Zurück zum Zitat Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobashi Y, Oka M (2007) Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 56:1625–1629CrossRefPubMed Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobashi Y, Oka M (2007) Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 56:1625–1629CrossRefPubMed
8.
Zurück zum Zitat Morozumi M, Takahashi T, Ubukata K (2010) Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 16:78–86CrossRefPubMed Morozumi M, Takahashi T, Ubukata K (2010) Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 16:78–86CrossRefPubMed
9.
Zurück zum Zitat Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M; Atypical Pathogen Study Group (2010) Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int J Antimicrob Agents 36:384–385CrossRefPubMed Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M; Atypical Pathogen Study Group (2010) Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int J Antimicrob Agents 36:384–385CrossRefPubMed
10.
Zurück zum Zitat Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T (2004) Is it possible to distinguish between atypical pneumonia and bacterial pneumonia?: evaluation of the guidelines for community-acquired pneumonia in Japan. Respir Med 98:952–960CrossRefPubMed Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T (2004) Is it possible to distinguish between atypical pneumonia and bacterial pneumonia?: evaluation of the guidelines for community-acquired pneumonia in Japan. Respir Med 98:952–960CrossRefPubMed
11.
Zurück zum Zitat Ishida T, Miyashita N, Nakahama C (2007) Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology 12:104–110CrossRefPubMed Ishida T, Miyashita N, Nakahama C (2007) Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology 12:104–110CrossRefPubMed
12.
Zurück zum Zitat Alexander TS, Gray LD, Kraft JA, Leland DS, Nikaido MT, Willis DH (1996) Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial. J Clin Microbiol 34:1180–1183PubMed Alexander TS, Gray LD, Kraft JA, Leland DS, Nikaido MT, Willis DH (1996) Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial. J Clin Microbiol 34:1180–1183PubMed
13.
Zurück zum Zitat Matas L, Domínguez J, De Ory F, García N, Galí N, Cardona PJ, Hernández A, Rodrigo C, Ausina V (1998) Evaluation of Meridian ImmunoCard Mycoplasma test for the detection of Mycoplasma pneumoniae-specific IgM in paediatric patients. Scand J Infect Dis 30:289–293CrossRefPubMed Matas L, Domínguez J, De Ory F, García N, Galí N, Cardona PJ, Hernández A, Rodrigo C, Ausina V (1998) Evaluation of Meridian ImmunoCard Mycoplasma test for the detection of Mycoplasma pneumoniae-specific IgM in paediatric patients. Scand J Infect Dis 30:289–293CrossRefPubMed
14.
Zurück zum Zitat Dunn JJ, Malan AK, Evans J, Litwin CM (2004) Rapid detection of Mycoplasma pneumoniae IgM antibodies in pediatric patients using ImmunoCard Mycoplasma compared to conventional enzyme immunoassays. Eur J Clin Microbiol Infect Dis 23:412–414CrossRefPubMed Dunn JJ, Malan AK, Evans J, Litwin CM (2004) Rapid detection of Mycoplasma pneumoniae IgM antibodies in pediatric patients using ImmunoCard Mycoplasma compared to conventional enzyme immunoassays. Eur J Clin Microbiol Infect Dis 23:412–414CrossRefPubMed
15.
Zurück zum Zitat Miyashita N, Sugiu T, Kawai Y, Oda K, Yamaguchi T, Ouchi K, Kobashi Y, Oka M (2009) Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging 9:7CrossRefPubMed Miyashita N, Sugiu T, Kawai Y, Oda K, Yamaguchi T, Ouchi K, Kobashi Y, Oka M (2009) Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging 9:7CrossRefPubMed
16.
Zurück zum Zitat Ito I, Ishida T, Togashi K, Niimi A, Koyama H, Ishimori T, Kobayashi H, Mishima M (2009) Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography. Eur J Radiol 72:388–395CrossRefPubMed Ito I, Ishida T, Togashi K, Niimi A, Koyama H, Ishimori T, Kobayashi H, Mishima M (2009) Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography. Eur J Radiol 72:388–395CrossRefPubMed
17.
Zurück zum Zitat Miyashita N, Obase Y, Fukuda M, Shouji H, Yoshida K, Ouchi K, Oka M (2007) Evaluation of the diagnostic usefulness of real-time PCR for detection of Chlamydophila pneumoniae in acute respiratory infections. J Infect Chemother 13:183–187CrossRefPubMed Miyashita N, Obase Y, Fukuda M, Shouji H, Yoshida K, Ouchi K, Oka M (2007) Evaluation of the diagnostic usefulness of real-time PCR for detection of Chlamydophila pneumoniae in acute respiratory infections. J Infect Chemother 13:183–187CrossRefPubMed
18.
Zurück zum Zitat Ramirez JA, Ahkee S, Tolentino A, Miller RD, Summersgill JT (1996) Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn Microbiol Infect Dis 24:7–14CrossRefPubMed Ramirez JA, Ahkee S, Tolentino A, Miller RD, Summersgill JT (1996) Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn Microbiol Infect Dis 24:7–14CrossRefPubMed
19.
Zurück zum Zitat Koide M, Higa F, Tateyama M, Sakugawa H, Saito A (2004) Comparison of polymerase chain reaction and two urinary antigen detection kits for detecting Legionella in clinical samples. Eur J Clin Microbiol Infect Dis 23:221–223CrossRefPubMed Koide M, Higa F, Tateyama M, Sakugawa H, Saito A (2004) Comparison of polymerase chain reaction and two urinary antigen detection kits for detecting Legionella in clinical samples. Eur J Clin Microbiol Infect Dis 23:221–223CrossRefPubMed
20.
Zurück zum Zitat Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed
21.
Zurück zum Zitat Ozaki T, Nishimura N, Ahn J, Watanabe N, Muto T, Saito A, Koyama N, Nakane K, Funahashi K (2007) Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates. J Infect Chemother 13:204–207CrossRefPubMed Ozaki T, Nishimura N, Ahn J, Watanabe N, Muto T, Saito A, Koyama N, Nakane K, Funahashi K (2007) Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates. J Infect Chemother 13:204–207CrossRefPubMed
22.
Zurück zum Zitat Niki Y, Hanaki H, Matsumoto T, Yagisawa M, Kohno S, Aoki N et al (2009) Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens’ antibacterial susceptibility. J Infect Chemother 15:156–167CrossRefPubMed Niki Y, Hanaki H, Matsumoto T, Yagisawa M, Kohno S, Aoki N et al (2009) Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens’ antibacterial susceptibility. J Infect Chemother 15:156–167CrossRefPubMed
23.
Zurück zum Zitat Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH et al (2004) High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48:2101–2107CrossRefPubMed Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH et al (2004) High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48:2101–2107CrossRefPubMed
24.
Zurück zum Zitat Inoue M, Lee NY, Hong SW, Lee K, Felmingham D (2004) PROTEKT 1999–2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents 23:44–51CrossRefPubMed Inoue M, Lee NY, Hong SW, Lee K, Felmingham D (2004) PROTEKT 1999–2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents 23:44–51CrossRefPubMed
25.
Zurück zum Zitat Yokota S, Sato K, Yoshida S, Fujii N (2004) Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan. Kansenshogaku Zasshi 78:428–434 (in Japanese)PubMed Yokota S, Sato K, Yoshida S, Fujii N (2004) Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan. Kansenshogaku Zasshi 78:428–434 (in Japanese)PubMed
26.
Zurück zum Zitat Yokota S, Ohkoshi Y, Sato K, Fujii N (2008) Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children. J Clin Microbiol 46:361–365CrossRefPubMed Yokota S, Ohkoshi Y, Sato K, Fujii N (2008) Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children. J Clin Microbiol 46:361–365CrossRefPubMed
Metadaten
Titel
Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults
verfasst von
N. Miyashita
Y. Kawai
T. Yamaguchi
K. Ouchi
M. Oka
Atypical Pathogen Study Group
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2011
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-1107-8

Weitere Artikel der Ausgabe 3/2011

European Journal of Clinical Microbiology & Infectious Diseases 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.